首页> 外文期刊>Journal of critical care >Risk prediction of hospital mortality for adult patients admitted to Australian and New Zealand intensive care units: Development and validation of the Australian and New Zealand Risk of Death model
【24h】

Risk prediction of hospital mortality for adult patients admitted to Australian and New Zealand intensive care units: Development and validation of the Australian and New Zealand Risk of Death model

机译:澳大利亚和新西兰重症监护病房收治的成年患者住院死亡率的风险预测:澳大利亚和新西兰死亡风险模型的开发和验证

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose: The purpose of this study is to develop and validate a new mortality prediction model (Australian and New Zealand Risk of Death [ANZROD]) for Australian and New Zealand intensive care units (ICUs) and compare its performance with the existing Acute Physiology and Chronic Health Evaluation (APACHE) III-j. Materials and Methods: All ICU admissions from 2004 to 2009 were extracted from the Australian and New Zealand Intensive Care Society Adult Patient Database. Hospital mortality was modeled using logistic regression with training (two third) and validation (one third) data sets. Predictor variables included APACHE III score components, source of admission to ICU and hospital, lead time, elective surgery, treatment limitation, ventilation status, and APACHE III diagnoses. Model performance was assessed by standardized mortality ratio, Hosmer-Lemeshow C and H statistics, Brier score, Cox calibration regression, area under the receiver operating characteristic curve, and calibration curves. Results: There were 456. 605 patients available for model development and validation. Observed mortality was 11.3%. Performance measures (standardized mortality ratio, Hosmer-Lemeshow C and H statistics, and receiver operating characteristic curve) for the ANZROD and APACHE III-j model in the validation data set were 1.01, 104.9 and 111.4, and 0.902; 0.84, 1596.6 and 2087.3, and 0.885, respectively. Conclusions: The ANZROD has better calibration; discrimination compared with the APACHE III-j. Further research is required to validate performance over time and in specific subgroups of ICU population.
机译:目的:本研究的目的是为澳大利亚和新西兰的重症监护病房(ICU)开发并验证一种新的死亡率预测模型(澳大利亚和新西兰的死亡风险[ANZROD]),并将其性能与现有的急性生理学和慢性健康评估(APACHE)III-j。材料和方法:2004年至2009年的所有ICU入院病例均摘自澳大利亚和新西兰的重症监护协会成人患者数据库。使用训练(三分之二)和验证(三分之一)数据集的逻辑回归对医院死亡率进行建模。预测变量包括APACHE III评分成分,ICU和医院的入院来源,前置时间,选择性手术,治疗限制,通气状态和APACHE III诊断。模型性能通过标准化死亡率,Hosmer-Lemeshow C和H统计数据,Brier得分,Cox校准回归,接收器工作特性曲线下的面积以及校准曲线进行评估。结果:共有456. 605名患者可供模型开发和验证。观察到的死亡率为11.3%。验证数据集中ANZROD和APACHE III-j模型的性能指标(标准化死亡率,Hosmer-Lemeshow C和H统计数据以及接收器工作特性曲线)分别为1.01、104.9和111.4和0.902;分别为0.84、1596.6和2087.3和0.885。结论:ANZROD具有更好的校准效果。与APACHE III-j相比存在歧视。需要进一步的研究以验证一段时间内和ICU人群特定亚组的表现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号